Compare MP Materials (MP) vs Novo Nordisk A/S (NVO) Price & Performance

MP MaterialsTrade

Novo Nordisk A/STrade

Price performance (Past 24H)

Key statistics

MP Materials vs Novo Nordisk A/S — how do they compare? MP Materials trades at $46.67 (market cap $8.22B), while Novo Nordisk A/S trades at $38.12 (market cap $165.31B). The key difference: Novo Nordisk A/S is far larger — about 20.1× MP Materials's market cap, and Novo Nordisk A/S pays a 4.71% dividend while MP Materials pays none. Which is the better fit depends on your goals — on Pluang, investors hold MP Materials for 11 Days and Novo Nordisk A/S for 116 Days on average.

	MP	NVO
Market Cap	$8.22B	$165.31B
Volume	5,457,792	11,432,838
Sector	Basic Materials	Health
52-Week High	$98.65	$63.98
52-Week Low	$38.10	$35.29
Typical Hold Time	11 Days	116 Days
Enterprise Value	$7.70B	$179.56B
Dividend Yield	—	4.71%

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

MP Materials

No Aura AI signal available yet.

Novo Nordisk A/S

Novo Nordisk (NVO) trades at $38.26, up 1.95% today, with strong fundamentals including 35.35% net margin and 59.82% ROE. The stock shows mixed technical signals with bullish oscillators but bearish moving averages. Recent earnings consistently beat expectations, with Q2 2026 EPS of $0.96 surpassing the $0.82 estimate. The company maintains robust cash flow generation with $119.1B operating cash flow in 2025.

NVO presents compelling value with a 9.71 P/E ratio below industry averages and 59% analyst buy ratings. Upside potential exists to the $44.67 consensus target, though competition from Eli Lilly and FDA regulatory delays pose near-term risks. The obesity drug pipeline remains a key growth driver, supported by recent licensing deals totaling nearly $4B.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

81% Buy19% Sell

Avg holding period · 11 Days

NVO

68% Buy32% Sell

Avg holding period · 116 Days

Top news

Latest headlines on both assets

Critical metals stocks fall again; builders like USA Rare Earth drop sharply, producers like MP Materials hold better.24/7 Wall Street · 21 hours agoBearish Rare earth stocks drop 3-5% amid sector-wide selloff without company-specific news.24/7 Wall Street · 2 days agoBearish Pentagon invests $400M in MP Materials to break China's rare earth magnet monopoly, GM first to receive non-China magnets.24/7 Wall Street · 4 days agoBullish View details →

NVO

Novo Nordisk rated Buy over Eli Lilly due to valuation discount and steady growth prospects.Seeking Alpha · 1 day agoBullish Oral GLP-1 drugs market to grow from $5.1B in 2026 to $89B by 2034, driven by new delivery tech and patient preference.TheNewswire · 3 days agoBullish View details →

About MP Materials

MP Materials mines, refines, and manufactures rare earth materials and magnets in the United States. Its products are used in transportation, energy, robotics, defense, and aerospace applications.

About Novo Nordisk A/S

With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.